Steve Schonfeld’s Novo Nordisk NVO Stock Holding History

Steve Schonfeld’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.82M	Buy	+38,000	New	+$1.63M	0.01%	1117
2026 Q1	–	Sell	-100,500	Closed	-$5.11M	–	2523
2025 Q4	$5.11M	Hold	100,500	–	–	0.02%	533
2025 Q3	$5.58M	Buy	+100,500	New	+$5.88M	0.03%	551
2023 Q3	–	Sell	-200,000	Closed	-$210K	–	2130
2023 Q2	$210K	Hold	200,000	–	–	﹤0.01%	1542
2023 Q1	$320K	Buy	+200,000	New	+$14.2M	﹤0.01%	1347

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Steve Schonfeld's NVO Position: Q2 2026 in Review

Steve Schonfeld reduced its Novo Nordisk (NVO) stake by 87% in Q2 2026, selling an estimated $3.83M and leaving 12,964 shares worth $621K. The position accounts for ﹤0.01% of the portfolio, ranked #1720.

Steve Schonfeld first reported a position in NVO in Q1 2016 and has held it in 22 quarters since. The position peaked at $30.9M in Q3 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Steve Schonfeld held 12,964 shares of Novo Nordisk worth $621K as of Q2 2026.
Steve Schonfeld sold 89,076 Novo Nordisk shares in Q2 2026, an estimated $3.83M.
Novo Nordisk made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #1720 holding.
Steve Schonfeld first reported a position in Novo Nordisk in Q1 2016 and has held it in 22 quarters since.
Steve Schonfeld's Novo Nordisk position peaked at $30.9M in Q3 2025.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.